The inhibition of IDO restored the proliferation of tumor-specific T cells with less toxicity, indicating that IDO might be favorable more so in individuals who are already at risk of developing detrimental adverse effects, as in the case of HIV infection [105]. The gene discussed is IDO1; the disease is HIV infectious disease.